Transgenic biosynthesis of trypanothione protects escherichia coli from radiation-induced toxicity

Matthew P. Fitzgerald, Joshua M. Madsen, Mitchell C. Coleman, Melissa LT Teoh-Fitzgerald, Scott G Westphal, Douglas R. Spitz, Rafael Radi, Frederick E. Domann

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Trypanothione is a unique diglutathionyl-spermidine conjugate found in abundance in trypanosomes but not in other eukaryotes. Because trypanothione is a naturally occurring polyamine thiol reminiscent of the synthetic drug amifostine, it may be a useful protector against radiation and oxidative stress. For these reasons we hypothesized that trypanothione might serve as a radioprotective agent when produced in bacteria. To accomplish this objective, the trypanothione synthetase and reductase genes from T. cruzi were introduced into E. coli and their expression was verified by qPCR and immunoblotting. Trypanothione synthesis in bacteria, detected by HPLC, resulted in decreased intracellular levels of reactive oxygen species as determined by H2DCFDA oxidation. Moreover, E. coli genomic DNA was protected from radiation-induced DNA damage by 4.6-fold in the presence of trypanothione compared to control bacteria. Concordantly, the transgenic E. coli expressing trypanothione were 4.3-fold more resistant to killing by 137Cs radiation compared to E. coli devoid of trypanothione expression. Thus we have shown for the first time that E. coli can be genetically engineered to express the trypanothione biosynthetic pathway and produce trypanothione, which results in their radioresistance. These results warrant further research to explore the possibility of developing trypanothione as a novel radioprotective agent.

Original languageEnglish (US)
Pages (from-to)290-296
Number of pages7
JournalRadiation Research
Volume174
Issue number3
DOIs
StatePublished - Jan 1 2010

Fingerprint

biosynthesis
antiradiation drugs
Escherichia
toxicity
bacteria
Radiation
Escherichia coli
trypanosome
radiation
deoxyribonucleic acid
eukaryotes
protectors
thiols
genes
Radiation-Protective Agents
drugs
damage
trypanothione synthetase
oxidation
Bacteria

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation
  • Medicine(all)

Cite this

Transgenic biosynthesis of trypanothione protects escherichia coli from radiation-induced toxicity. / Fitzgerald, Matthew P.; Madsen, Joshua M.; Coleman, Mitchell C.; Teoh-Fitzgerald, Melissa LT; Westphal, Scott G; Spitz, Douglas R.; Radi, Rafael; Domann, Frederick E.

In: Radiation Research, Vol. 174, No. 3, 01.01.2010, p. 290-296.

Research output: Contribution to journalArticle

Fitzgerald, Matthew P. ; Madsen, Joshua M. ; Coleman, Mitchell C. ; Teoh-Fitzgerald, Melissa LT ; Westphal, Scott G ; Spitz, Douglas R. ; Radi, Rafael ; Domann, Frederick E. / Transgenic biosynthesis of trypanothione protects escherichia coli from radiation-induced toxicity. In: Radiation Research. 2010 ; Vol. 174, No. 3. pp. 290-296.
@article{a838ec3f530e49bb8669df5ae99b5d7a,
title = "Transgenic biosynthesis of trypanothione protects escherichia coli from radiation-induced toxicity",
abstract = "Trypanothione is a unique diglutathionyl-spermidine conjugate found in abundance in trypanosomes but not in other eukaryotes. Because trypanothione is a naturally occurring polyamine thiol reminiscent of the synthetic drug amifostine, it may be a useful protector against radiation and oxidative stress. For these reasons we hypothesized that trypanothione might serve as a radioprotective agent when produced in bacteria. To accomplish this objective, the trypanothione synthetase and reductase genes from T. cruzi were introduced into E. coli and their expression was verified by qPCR and immunoblotting. Trypanothione synthesis in bacteria, detected by HPLC, resulted in decreased intracellular levels of reactive oxygen species as determined by H2DCFDA oxidation. Moreover, E. coli genomic DNA was protected from radiation-induced DNA damage by 4.6-fold in the presence of trypanothione compared to control bacteria. Concordantly, the transgenic E. coli expressing trypanothione were 4.3-fold more resistant to killing by 137Cs radiation compared to E. coli devoid of trypanothione expression. Thus we have shown for the first time that E. coli can be genetically engineered to express the trypanothione biosynthetic pathway and produce trypanothione, which results in their radioresistance. These results warrant further research to explore the possibility of developing trypanothione as a novel radioprotective agent.",
author = "Fitzgerald, {Matthew P.} and Madsen, {Joshua M.} and Coleman, {Mitchell C.} and Teoh-Fitzgerald, {Melissa LT} and Westphal, {Scott G} and Spitz, {Douglas R.} and Rafael Radi and Domann, {Frederick E.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1667/RR2235.1",
language = "English (US)",
volume = "174",
pages = "290--296",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "3",

}

TY - JOUR

T1 - Transgenic biosynthesis of trypanothione protects escherichia coli from radiation-induced toxicity

AU - Fitzgerald, Matthew P.

AU - Madsen, Joshua M.

AU - Coleman, Mitchell C.

AU - Teoh-Fitzgerald, Melissa LT

AU - Westphal, Scott G

AU - Spitz, Douglas R.

AU - Radi, Rafael

AU - Domann, Frederick E.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Trypanothione is a unique diglutathionyl-spermidine conjugate found in abundance in trypanosomes but not in other eukaryotes. Because trypanothione is a naturally occurring polyamine thiol reminiscent of the synthetic drug amifostine, it may be a useful protector against radiation and oxidative stress. For these reasons we hypothesized that trypanothione might serve as a radioprotective agent when produced in bacteria. To accomplish this objective, the trypanothione synthetase and reductase genes from T. cruzi were introduced into E. coli and their expression was verified by qPCR and immunoblotting. Trypanothione synthesis in bacteria, detected by HPLC, resulted in decreased intracellular levels of reactive oxygen species as determined by H2DCFDA oxidation. Moreover, E. coli genomic DNA was protected from radiation-induced DNA damage by 4.6-fold in the presence of trypanothione compared to control bacteria. Concordantly, the transgenic E. coli expressing trypanothione were 4.3-fold more resistant to killing by 137Cs radiation compared to E. coli devoid of trypanothione expression. Thus we have shown for the first time that E. coli can be genetically engineered to express the trypanothione biosynthetic pathway and produce trypanothione, which results in their radioresistance. These results warrant further research to explore the possibility of developing trypanothione as a novel radioprotective agent.

AB - Trypanothione is a unique diglutathionyl-spermidine conjugate found in abundance in trypanosomes but not in other eukaryotes. Because trypanothione is a naturally occurring polyamine thiol reminiscent of the synthetic drug amifostine, it may be a useful protector against radiation and oxidative stress. For these reasons we hypothesized that trypanothione might serve as a radioprotective agent when produced in bacteria. To accomplish this objective, the trypanothione synthetase and reductase genes from T. cruzi were introduced into E. coli and their expression was verified by qPCR and immunoblotting. Trypanothione synthesis in bacteria, detected by HPLC, resulted in decreased intracellular levels of reactive oxygen species as determined by H2DCFDA oxidation. Moreover, E. coli genomic DNA was protected from radiation-induced DNA damage by 4.6-fold in the presence of trypanothione compared to control bacteria. Concordantly, the transgenic E. coli expressing trypanothione were 4.3-fold more resistant to killing by 137Cs radiation compared to E. coli devoid of trypanothione expression. Thus we have shown for the first time that E. coli can be genetically engineered to express the trypanothione biosynthetic pathway and produce trypanothione, which results in their radioresistance. These results warrant further research to explore the possibility of developing trypanothione as a novel radioprotective agent.

UR - http://www.scopus.com/inward/record.url?scp=77956203926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956203926&partnerID=8YFLogxK

U2 - 10.1667/RR2235.1

DO - 10.1667/RR2235.1

M3 - Article

VL - 174

SP - 290

EP - 296

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 3

ER -